Get started
Author

Stuart H. Ratcliffe

Observed names: S Ratcliffe, S. Ratcliffe, S.H.R. Ratcliffe, STUART RATCLIFFE, Sophie Ratcliffe, Stuart Ratcliffe
Observed institutions: St Bartholomew's Hospital, Barts Health NHS Trust, Royal Berkshire Hospital, Gartnavel General Hospital, Battle Hospital, St Pancras Hospital, MAC Clinical Research (United Kingdom), University of KwaZulu-Natal, Grünenthal Group (Germany)
OpenAlex ID: A5108246691
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
2011 · A. Novotna, J. Mares, et al. · European Journal of Neurology · 492
Randomized controlled trial of cannabis‐based medicine in spasticity caused by multiple sclerosis
2007 · C. Collin, P. Davies, et al. · European Journal of Neurology · 387
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
2012 · R. M. Langford, J. Mares, et al. · Journal of Neurology · 309
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
2010 · C. Collin, E. Ehler, et al. · Neurological Research · 286
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
2016 · Khalid A. Jadoon, Stuart H. Ratcliffe, et al. · Diabetes Care · 276
A double‐blind, randomized, placebo‐controlled, parallel group study of THC / CBD spray in peripheral neuropathic pain treatment
2014 · M. Serpell, S. Ratcliffe, et al. · European Journal of Pain · 205
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)
2011 · W Notcutt, R Langford, et al. · Multiple Sclerosis Journal · 166
PDF
Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: A randomized, placebo‐controlled trial
2006 · Richard Langford, Frank McKenna, et al. · Arthritis & Rheumatism · 108
A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain
2014 · B. Hoggart, S. Ratcliffe, et al. · Journal of Neurology · 92
A randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia
2013 · Jarkko Kalliomäki, Nadine Attal, et al. · Pain · 79
The respiratory effects of tramadol in children under halothane anaesthesia
1998 · A. T. Bösenberg, S. Ratcliffe · Anaesthesia · 52
PDF
A randomized study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist mavatrep in patients with osteoarthritis
2017 · Arthur J. Mayorga, Christopher M. Flores, et al. · Scandinavian Journal of Pain · 50
Intraindividual Differences in Pain Relief and Functional Improvement in Osteoarthritis with Diclofenac or Tramadol
1998 · Karel Pavelka, Zuzana Peliskov??, et al. · Clinical Drug Investigation · 42
A Randomized Comparison of Parecoxib/valdecoxib and Placebo for the Prevention of Cystoid Macular Edema After Scleral Buckling Surgery
2009 · SARAH E. BENSON, STUART RATCLIFFE, et al. · Retina · 13
Randomized controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in adults with complex regional pain syndrome
2022 · Stuart Ratcliffe, Dimitrios Arkilo, et al. · Pain Medicine · 6
PDF
Sativex® in the treatment of pain of neurological origin or symptoms of Multiple Sclerosis: Interim analysis of a long-term, open label, safety and tolerability study
2005 · M. Serpell, S. Ratcliffe, et al. · Journal of Pain · 1
PDF
A Phase 2 randomised, double-blind, placebo-controlled trial of emestedastat in patients with major depressive disorder and cognitive impairment
2026 · Jack D. Taylor, Paul E. Rolan, et al. · The British Journal of Psychiatry
PDF
XanaCIDD: A clinical study in which participants are randomly assigned to take either active drug or placebo (non active) to assess if the drug Xanamem is safe, tolerable and effective in helping adult patients with cognitive impairment due to depressive disorder
2023 · Dana Hilt, Stuart Ratcliffe, et al. · http://isrctn.com/
Double-blind, randomised, placebo controlled, parallel group study of sativex® in the treatment of patients with peripheral neuropathic pain, associated with allodynia [poster]
2009 · Mick Serpell, S. Ratcliffe, et al. · ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)
PDF
Stable dose cannabinoid medicine (Sativex®, THC+CBD) can provide sustained efficacy in the treatment of refractory painful diabetic neuropathy or other peripheral neuropathic pain associated with allodynia [poster]
2008 · S. Ratcliffe, Mick Serpell, et al. · ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)
PDF
A prospective, randomised, double-blind, double-dummy, placebo-controlled trial to assess the respiratory effects of buprenorphine versus morphine in anaesthetised patients
2008 · Sonja Nikolić, Vivek Mehta, et al. · City Research Online (City University London)
PDF
241 Differing Attitudes to Analgesic Options in Post‐herpetic Neuralgia Patients: Parallel Surveys Conducted in 100 Patients and 1078 Gps in 2006
2007 · S.H.R. Ratcliffe, E. Hennessy, et al. · European Journal of Pain
A Randomised, Single-Dose, Two-Period, Cross-Over Phase I Pharmacokinetic Study to Compare TDS®-Diazepam with Rectal Diazepam in Healthy Adult Subjects
2006 · Fatimah Alotaibi, Ashley T. Tucker, et al.
Transdermal fentanyl in osteoarthritis: A randomized, double-blind, placebo-controlled trial
2005 · R. Langford, F. McKenna, et al. · Journal of Pain
PDF
Opioids in non-cancer pain
2004 · A. de Kater, E. Jonnson, et al. · Journal of Pain
Works count: 26
Citation count: 2,564
H-index: 13
I10-index: 14
Year
Topic
Type